1. Home
  2. BDTX vs CURR Comparison

BDTX vs CURR Comparison

Compare BDTX & CURR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDTX
  • CURR
  • Stock Information
  • Founded
  • BDTX 2014
  • CURR 2013
  • Country
  • BDTX United States
  • CURR Singapore
  • Employees
  • BDTX N/A
  • CURR N/A
  • Industry
  • BDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • CURR Business Services
  • Sector
  • BDTX Health Care
  • CURR Consumer Discretionary
  • Exchange
  • BDTX Nasdaq
  • CURR Nasdaq
  • Market Cap
  • BDTX 181.4M
  • CURR 151.4M
  • IPO Year
  • BDTX 2020
  • CURR N/A
  • Fundamental
  • Price
  • BDTX $2.76
  • CURR $1.70
  • Analyst Decision
  • BDTX Strong Buy
  • CURR Strong Buy
  • Analyst Count
  • BDTX 5
  • CURR 1
  • Target Price
  • BDTX $13.40
  • CURR $3.50
  • AVG Volume (30 Days)
  • BDTX 914.3K
  • CURR 591.8K
  • Earning Date
  • BDTX 08-07-2025
  • CURR 08-04-2025
  • Dividend Yield
  • BDTX N/A
  • CURR N/A
  • EPS Growth
  • BDTX N/A
  • CURR N/A
  • EPS
  • BDTX 0.25
  • CURR N/A
  • Revenue
  • BDTX $70,000,000.00
  • CURR $41,092,419.00
  • Revenue This Year
  • BDTX N/A
  • CURR N/A
  • Revenue Next Year
  • BDTX N/A
  • CURR $21.53
  • P/E Ratio
  • BDTX $11.03
  • CURR N/A
  • Revenue Growth
  • BDTX N/A
  • CURR N/A
  • 52 Week Low
  • BDTX $1.20
  • CURR $0.33
  • 52 Week High
  • BDTX $6.75
  • CURR $7.08
  • Technical
  • Relative Strength Index (RSI)
  • BDTX 52.31
  • CURR N/A
  • Support Level
  • BDTX $2.22
  • CURR N/A
  • Resistance Level
  • BDTX $2.84
  • CURR N/A
  • Average True Range (ATR)
  • BDTX 0.20
  • CURR 0.00
  • MACD
  • BDTX -0.01
  • CURR 0.00
  • Stochastic Oscillator
  • BDTX 72.00
  • CURR 0.00

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

About CURR Currenc Group Inc. Ordinary Shares

Currenc Group Inc is a fintech pioneer dedicated to transforming financial services through artificial intelligence (AI). It empowers financial institutions with comprehensive AI solutions, including the SEAMLESS AI Call Centre and other AI-powered tools designed to reduce costs, increase efficiency, and boost customer satisfaction. The Company's digital remittance platform also enables e-wallets, remittance companies, and corporations to provide real-time, 24/7 payment services, advancing financial access across underserved communities. It generates the majority of its geographic revenue from Malaysia.

Share on Social Networks: